By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050



Company News
Teva (TEVA) Announces U.S. Availability Of ZECUITY (Sumatriptan Iontophoretic Transdermal System), First And Only Transdermal Patch System For The Acute Treatment Of Migraine 9/1/2015 11:10:22 AM
FTC May Require Products Worth $600 Million to be Divested for Teva (TEVA)-Allergan (AGN) Deal to Go Through 8/27/2015 7:03:35 AM
Teva (TEVA) Announces FDA Acceptance Of NDA For SD-809 For Treatment In Huntington Disease 8/12/2015 10:56:39 AM
Former Teva (TEVA) CEO Banks $75 Million for Neurology Startup Ovid 8/11/2015 10:40:28 AM
Amidst Allergan (AGN) Acquisition and Immuneering Investment, Teva (TEVA) Slashes More Jobs in Virginia 8/6/2015 6:52:16 AM
Teva (TEVA)-Allergan (AGN) Deal Underscores Generics Market Consolidation with 90% of US Buying Generic Pills from A Single Company 8/5/2015 6:36:02 AM
Sagent Pharma Appoints Ex-Teva (TEVA) Exec Allan Oberman as CEO 8/4/2015 6:15:17 AM
Teva (TEVA) Secures $33.75 Billion Financing Commitment 8/3/2015 11:46:18 AM
Teva (TEVA) And Immuneering Announce Teva’s Purchase Of 51% Equity Share Of Genomic-Analysis Company 8/3/2015 10:25:00 AM
The Tale Of Two Teva (TEVA) 7/31/2015 6:25:01 AM